Debevoise & Plimpton advised Carlyle in the transaction. Carlyle (NASDAQ: CG) announced its strategic partnership with Orsini Specialty Pharmacy, the leading independent specialty pharmacy focused on rare...
You must be a Standard 1 Year member to access this content.
J.P. Morgan Securities LLC acted as financial advisor and Kirkland & Ellis LLP acted as legal advisor to Envista on the transaction. Debevoise & Plimpton advised...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton has advised Carlyle on the deal, while Kirkland & Ellis has advised GTCR and its portfolio company Resonetics. Carlyle (NASDAQ: CG) executed its acquisition...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton advised Blackstone Growth in the transaction while Gunderson Dettmer Stough Villeneuve Franklin & Hachigiam represented GSR Ventures and Tiger Global. Medable Inc., the...
You must be a Standard 1 Year member to access this content.
Sullivan & Cromwell advised Saama Technologies, Debevoise & Plimpton advised Carlyle, and Fenwick & West advised the syndicate on the deal. Carlyle (NASDAQ: CG) executed its...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Fort Dearborn, Debevoise & Plimpton LLP advised CD&R on the transaction, while Latham & Watkins LLP represented Platinum Equity and Multi-Color Corporation....
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton LLP advised Kelso & Company, while Winston & Strawn LLP served as legal counsel to Ferraro Foods in the transaction. Kelso & Company...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton LLP represented The Blackstone Group in the transaction while Wilson Sonsini Goodrich & Rosati advised Ginger. Ginger raised a $100 million Series E financing...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton LLP is advising Canada Pension Plan Investment Board (CPP Investments) as the lead investor in the transaction. insitro completed its $400 million Series C...
You must be a Standard 1 Year member to access this content.
